BRIDGEBIO PHARMA INC (BBIO) Institutional Ownership and Insiders Activity
BRIDGEBIO PHARMA INC (BBIO) is widely held by institutional investors, with 451 firms reporting positions valued at approximately $11.03B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Janus Henderson Group Plc is the largest disclosed holder, reporting approximately $957.70M in BBIO holdings in its latest filing.
Recent insider activity includes 10 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
451
Total Reported Value
$11.03B
Largest Holder
Janus Henderson Group Plc
Largest Position
$957.70M
Insider Transactions (90d)
10
Latest Filing Quarter
Q3 2026
New Institutional Positions
90
Funds Exiting Positions
57
Top Institutional Owners
View all- Janus Henderson Group Plc$957.70M
- Blackrock, Inc.$683.58M
- Viking Global Investors$644.33M
- Wellington Management Group Llp$622.40M
- Kohlberg Kravis Roberts & Co. L.P.$543.57M
BBIO News
All news- KKR Portfolio Analysis: Significant Changes Observed in Q2 2026
Aug 20, 2026 · valut.ai
- Farallon Capital Management Llc: Recent Investment Activity Analysis
Aug 17, 2026 · valut.ai
Related BBIO Institutional Insights:
- BBIO 13F Institutional Holders
- BBIO Superinvestors
- BBIO Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BBIO Insider Trading & SEC Form 4 Activity
- BBIO Articles
- Top Institutional Investor Stock Rankings